Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019:23:18-100.
doi: 10.7812/TPP/18-100.

Osteonecrosis of the Hip: A Primer

Affiliations
Review

Osteonecrosis of the Hip: A Primer

Michelle J Lespasio et al. Perm J. 2019.

Abstract

In this report, we deliver a concise and up-to-date review of osteonecrosis, a pathologic, painful, and often disabling condition that is believed to result from the temporary or permanent disruption of blood supply to an affected area of bone. We will discuss the epidemiology (disease distribution), pathogenesis (mechanism of development), etiology (associated risk factors, causes, and disorders), clinical manifestations (reported symptoms and physical findings), diagnosis and classification, and treatment options for hip osteonecrosis.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

Dr Mont receives research support from and/or is a paid consultant for: the American Academy of Orthopaedic Surgeons (Rosemont, IL); CyMedica Orthopedics, Inc (Scottsdale, AZ); DJ Orthopedics (Vista, CA); Flexion Therapeutics (Burlington, MA); Johnson & Johnson (New Brunswick, NJ); National Institutes of Health (Rockville, MD); Ongoing Care Solutions Inc (Pinellas Park, FL); Orthosensor (Dania Beach, FL); Pacira (Parsippany-Troy Hills, NJ); PeerWell Inc (San Francisco, CA); Performance Dynamics Inc (Muncie, IN); Pfizer(New York, NY); Skye Biologics (El Segundo, CA); Stryker Corporation (Kalamazoo, MI), and TissueGene Inc (Rockville, MD). Dr Mont is on the editorial or governing board of: The Journal of Arthroplasty, the Journal of Knee Surgery, Orthopedics, and the International Journal of Surgical Techniques; he receives royalties from MicroPort Orthopedics Inc (Arlington, TN); and owns stock or stock options in PeerWell Inc (San Francisco, CA and USMI (Tacoma Park, MD). The author(s) have no other conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Left, radiograph of a healthy hip joint. Right, radiograph of a hip joint where the osteonecrosis has progressed to collapse of the femoral head.
Figure 2
Figure 2
Progression of osteonecrosis using the Ficat & Arlet classification system. Osteonecrosis can progress from a normal, healthy hip (Stage I) to the collapse of the femoral head (Stage IV).

References

    1. Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015 Sep 18;6(8):590–601. doi: 10.5312/wjo.v6.i8.590. . - DOI - PMC - PubMed
    1. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis) N Engl J Med. 1992 May 28;326(22):1473–9. doi: 10.1056/NEJM199205283262206. . - DOI - PubMed
    1. Jones LC, Mont MA. Osteonecrosis (avascular necrosis of bone) [Internet] Waltham, MA: UpToDate; 2018. Mar 21, [cited 2018 Apr 22]. Available from: www.uptodate.com/contents/osteonecrosis-avascular-necrosis-of-bone.
    1. Healthcare Cost and Utilization Project (HCUP) Overview of the National (Nationwide) Inpatient Sample (NIS) [Internet] Rockville, MD: Agency for Healthcare Research and Quality; 2018. Aug 13, [cited 2018 Sep 21]. Available from: www.hcup-us.ahrq.gov/nisoverview.jsp.
    1. Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: Current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993 Aug;23(1):47–69. doi: 10.1016/s0049-0172(05)80026-5. - DOI - PubMed

Publication types